Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
type: MedicalStudy
description: Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2019-11-13
end date: 2025-01-25
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03652441
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: University of Cologne
study subject: Classical Hodgkin Lymphoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Classical Hodgkin Lymphoma

AI Analytics
type: Organization